1 terminated. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Terminated 1 |
Follow E5564: new trials by email Literature Review of E5564 trials Research Report on E5564
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Eritoran (E5564) Administered IV Over 14 Days Prior to and During Bone Marrow Engraftment in BMT Patients Who Have Received Myeloablative Conditioning Treatment and Are Receiving Bone Marrow or Stem Cells From Matched Related Donors E5564 - Leukemia | Phase 1 | Terminated | Eisai Inc. | 30 | 2008-09-01 | 2014-07-11 |
Graft vs Host Disease (1) · Leukemia (1)
Eisai Inc. (1)
United States (1)
Kenneth Cooke (1)